
Just Because It’s Not on the Scan, Doesn’t Mean the Risk Is Gone: What You Should Know About Post-Cancer Monitoring
For many cancer patients, follow-up often means regularly scheduled CT or MRI scans, hoping to catch signs of recurrence early. But what if these imaging tools are only showing part of the picture? In truth, most imaging technologies only detect tumors once they’ve reached a certain size. When it comes to predicting whether cancer will return—or whether it might develop in the first place—conventional scans may not tell the whole story.
This is where newer tools, such as Onco-D-clare by RGCC, provide added value. Rather than detecting cancer that has already formed, this test evaluates your internal risk profile on a genetic and molecular level. It’s a proactive way to personalize your prevention strategy.








